Clinical Trial Update: Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating salsalate, venetoclax, and decitabine or azacitidine for acute myeloid leukemia and advanced myelodysplastic/myeloprolifera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia
• Myeloproliferative Neoplasm

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Decitabine (Decitabine)
• Salsalate (Salsalate)
• Venetoclax (venetoclax)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2023-05-24